科研成果详情

题名Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells
作者
发表日期2024-08-29
发表期刊Journal of biomaterials science. Polymer edition   影响因子和分区
语种英语
原始文献类型Journal Article
关键词Ovarian cancer cabazitaxel carmustine combination therapy liposomes
其他关键词POLYMERIC NANOCARRIERS ; COMBINATION ; CHEMOTHERAPY ; RESISTANT ; THERAPY
摘要Ovarian cancer is the primary cause of death from cancer in female patients. The existing treatments for ovarian cancer are restricted and ineffective in achieving a cure for the disease. To address this issue, we provide a novel approach to treating ovarian cancer by utilizing a liposomal carrier that effectively delivers the chemotherapeutic drugs carmustine (BCNU) and cabazitaxel (CTX). Initially, the combined impact of BCNU and CTX was confirmed, revealing that this impact reaches its maximum at a ratio of 1:2 mol/mol (BCNU/CTX). After that, the BC-Lipo co-delivery system was developed, which has a high capability for loading drugs (97.48% ± 1.14 for BCNU, 86.29% ± 3.03 for CTX). This system also has a sustained release profile and a beneficial long-circulating feature. The accumulation of BC-Lipo in tumors was dramatically enhanced compared to the accumulation of the free drug. Furthermore, BC-Lipo demonstrated similar levels of cytotoxicity to free BCNU and CTX (BCNU/CTX) when tested on HeLa cells in an in vitro model. Biochemical staining methods investigated the cancer cell's morphological examination. The apoptosis was confirmed by FITC-Annexin-V/PI staining by flow cytometry analysis. In addition, the investigation of fluorescence and protein markers examined the apoptosis mechanistic pathway, and the results indicated that BC-Lipo induced apoptosis due to mitochondrial membrane potential variation. This proof-of-concept study has established the probability of these BCNU-CTX combined treatments as active drug delivery nanocarriers for poorly soluble BCNU and CTX
出版者TAYLOR & FRANCIS LTD
ISSN0920-5063
EISSN1568-5624
DOI10.1080/09205063.2024.2387949
页数21
WOS类目Engineering, Biomedical ; Materials Science, Biomaterials ; Polymer Science
WOS研究方向Engineering ; Materials Science ; Polymer Science
WOS记录号WOS:001300324700001
收录类别PUBMED ; SCIE ; EI
EI入藏号20243616986065
EI主题词Computerized tomography
EI分类号102.1.1 ; 102.1.2 ; 102.2.1 ; 103 ; 1106.5 ; 746 Imaging Techniques ; 941.2 Acoustic Variables Measurements
URL查看原文
PubMed ID39207251
通讯作者地址[Gong, Jianming]3 Fuxue Xiang, Wenzhou 325000, Zhejiang, Peoples R China.
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/217687
专题附属第一医院
第一临床医学院(信息与工程学院)、附属第一医院
第一临床医学院(信息与工程学院)、附属第一医院_妇产科学
作者单位
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
第一作者单位附属第一医院;  妇产科学;  第一临床医学院(信息与工程学院)、附属第一医院
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Jianming Gong,Renqian Feng,Xiaoqing Fu,et al. Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells[J]. Journal of biomaterials science. Polymer edition,2024.
APA Jianming Gong, Renqian Feng, Xiaoqing Fu, Qi Lin, & Bicheng Wu. (2024). Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells. Journal of biomaterials science. Polymer edition.
MLA Jianming Gong,et al."Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells".Journal of biomaterials science. Polymer edition (2024).

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Jianming Gong]的文章
[Renqian Feng]的文章
[Xiaoqing Fu]的文章
百度学术
百度学术中相似的文章
[Jianming Gong]的文章
[Renqian Feng]的文章
[Xiaoqing Fu]的文章
必应学术
必应学术中相似的文章
[Jianming Gong]的文章
[Renqian Feng]的文章
[Xiaoqing Fu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。